Detalles de la búsqueda
1.
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study.
Lancet Oncol
; 23(12): 1558-1570, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36400106
2.
Population pharmacokinetics of zanidatamab, an anti-HER2 biparatopic antibody, in patients with advanced or metastatic cancer.
Cancer Chemother Pharmacol
; 90(5): 399-408, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36102999
3.
Hydroxychloroquine usage in US patients, their experiences of tolerability and adherence, and implications for treatment: survey results from 3127 patients with SLE conducted by the Lupus Foundation of America.
Lupus Sci Med
; 6(1): e000317, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31168400
4.
Personal sensors for the diagnosis and management of metabolic disorders.
IEEE Eng Med Biol Mag
; 22(1): 32-42, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12683060
Resultados
1 -
4
de 4
1
Próxima >
>>